Figure 7. Impact of relaxation interventions on blood pressure: findings from randomised controlled trials.

Figure 7Impact of relaxation interventions on blood pressure: findings from randomised controlled trials

†DerSimonian-Laird Weighted Mean Difference

Systolic BP: DL= −3.7 (95%CI: −6.0 to −1.3); Q:p = <0.001; Size: p = 0.41

Diastolic BP: DL= −3.5 (95% CI: −5.1 to −1.9); Q:p = <0.001; Size: p = 0.38

Trials with multiple treatment arms were combined before the estimation of overall effect

+F/U: Duration of follow up in weeks, months or years, N: Number randomised, and

r: relaxation therapy; b: biofeedback

From: 11, Lifestyle interventions

Cover of Hypertension
Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [Internet].
NICE Clinical Guidelines, No. 127.
National Clinical Guideline Centre (UK).
Copyright © 2011, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.